Viking Therapeutics has inked a $150m multi-year manufacturing deal with CordenPharma to secure the future supply of its ...

Supply Lines is a daily newsletter that tracks global trade. Sign up here.Most Read from BloombergTrump DEI Purge Hits ...

Thirty-six weeks of once-daily, oral baricitinib was associated with greater hair regrowth on the scalp, eyebrows and ...

President Trump threatened to impose a 200% tariff on EU wines and champagne unless the EU rescinds its 50% tax on US alcohol ...

It was perhaps not the welcome Irish Prime Minister Micheal Martin had hoped for on an annual US trip to mark Saint Patrick's ...

The two companies will work together on Zealand’s amylin analogue petrelintide as a monotherapy and in combination therapies.

European stocks look like newly good investments amid Trump's tariff war and US economic unpredictabilities. European defense stocks are particularly appealing.

The global market for acute migraine treatment is on a steady growth trajectory, with sales expected to rise from USD 2,700.7 million in 2024 to USD 4,194.1 million by 2034, reflecting a CAGR of 4.5% ...

PT: Why do you think Eli Lilly is coming out as a social media ... focused on six countries [US, Germany, France, Italy, UK and Japan]. The communities are smaller here, deliberately so ...

Use of nivolumab (Opdivo) before chemotherapy was not associated with improved pathologic complete response (pCR) rates among ...